Novel Cancer Diagnostic Earns Hao a PhRMA Grant
Liangliang Hao has earned a grant from the PhRMA Foundation for her proposal to develop a rapid point-of-care test that will predict the efficacy of some cancer treatment.
Liangliang Hao has earned a grant from the PhRMA Foundation for her proposal to develop a rapid point-of-care test that will predict the efficacy of some cancer treatment.